Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
PUT
Ligand Pharmaceuticals
LGND
$5.74B
| $6.96M | ﹤0.01% |
109,325
+54,663
| +100% | +$4.01M |
|
|
NVRO
1852
CALL
DELISTED
NEVRO CORP.
NVRO
| $6.95M | ﹤0.01% |
66,600
-76,400
| -53% | -$6.9M |
|
1853
Arrowhead Research
ARWR
$12.6B
| $6.95M | ﹤0.01% |
945,692
+435,565
| +85% | +$2.82M |
|
1854
PUT
Paychex
PAYX
$44.4B
| $6.94M | ﹤0.01% |
120,000
+400
| +0.3% | +$24K |
|
1855
PUT
U-Haul Holding Co
UHAL
$13.4B
| $6.94M | ﹤0.01% |
214,000
+31,000
| +17% | +$1.11M |
|
1856
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.62B
| $6.94M | ﹤0.01% |
+69,331
| New | +$6.94M |
|
1857
CALL
CoStar Group
CSGP
$13B
| $6.93M | ﹤0.01% |
320,000
+298,000
| +1,355% | +$6.34M |
|
1858
CALL
Huntington Ingalls Industries
HII
$11.7B
| $6.92M | ﹤0.01% |
45,100
+3,900
| +9% | +$647K |
|
|
N
1859
CALL
DELISTED
Netsuite Inc
N
| $6.92M | ﹤0.01% |
62,500
+7,300
| +13% | +$736K |
|
1860
CALL
Boston Properties
BXP
$11.2B
| $6.91M | ﹤0.01% |
50,700
+26,800
| +112% | +$3.72M |
|
1861
CALL
Sunoco
SUN
$14.1B
| $6.91M | ﹤0.01% |
238,100
+6,200
| +3% | +$186K |
|
|
RTN
1862
DELISTED
Raytheon Company
RTN
| $6.9M | ﹤0.01% |
50,700
-9,500
| -16% | -$1.32M |
|
1863
PUT
Flowserve
FLS
$10.5B
| $6.9M | ﹤0.01% |
143,000
+66,700
| +87% | +$3.17M |
|
1864
iShares Russell Mid-Cap Value ETF
IWS
$15.9B
| $6.89M | ﹤0.01% |
89,736
-174,252
| -66% | -$13.3M |
|
|
WUBA
1865
PUT
DELISTED
58.com Inc
WUBA
| $6.89M | ﹤0.01% |
144,500
-39,900
| -22% | -$1.95M |
|
1866
CALL
MBIA
MBI
$256M
| $6.89M | ﹤0.01% |
884,000
-147,200
| -14% | -$1.16M |
|
|
SPLS
1867
CALL
DELISTED
Staples Inc
SPLS
| $6.86M | ﹤0.01% |
802,800
-278,500
| -26% | -$2.45M |
|
1868
PUT
Mid-America Apartment Communities
MAA
$15.3B
| $6.86M | ﹤0.01% |
73,000
+8,600
| +13% | +$858K |
|
1869
CALL
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.9B
| $6.83M | ﹤0.01% |
156,400
+106,000
| +210% | +$4.65M |
|
1870
CALL
Norwegian Cruise Line
NCLH
$7.85B
| $6.83M | ﹤0.01% |
181,200
+99,700
| +122% | +$3.87M |
|
1871
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.19B
| $6.83M | ﹤0.01% |
99,598
+46,596
| +88% | +$3.14M |
|
1872
CALL
Charles River Laboratories
CRL
$14.1B
| $6.83M | ﹤0.01% |
81,900
+41,300
| +102% | +$3.46M |
|
|
SPLS
1873
PUT
DELISTED
Staples Inc
SPLS
| $6.83M | ﹤0.01% |
798,400
-45,600
| -5% | -$401K |
|
1874
PUT
Burlington
BURL
$19.8B
| $6.82M | ﹤0.01% |
84,200
-7,200
| -8% | -$557K |
|
1875
PUT
KKR & Co
KKR
$97.4B
| $6.82M | ﹤0.01% |
478,200
-149,900
| -24% | -$2.13M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.99B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,278 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.